Veterinary roundup highlights AI, dermatology, and nutrition bets: full analysis
A new Today’s Veterinary Business “Breaking News” roundup offers a useful snapshot of where veterinary industry momentum is heading: toward AI-enabled documentation, cloud-based practice software, specialty service expansion, and deeper ties between corporate players and academic veterinary medicine. The December 15, 2025 roundup spans product approvals, software launches, philanthropy, and specialty growth, but several items stand out because they point to broader structural shifts rather than one-off announcements. (todaysveterinarybusiness.com)
One of the clearest themes is digitization inside the clinic. UC Davis’ School of Veterinary Medicine adopted ScribbleVet across its clinical facilities, with the company and the publication emphasizing that the university conducted a security review and that clients can opt out. In parallel, Instinct Science launched Instinct EMR for Primary Care, positioning the platform around intelligent workflows, integrated payments, client communication, built-in drug reference support through Plumb’s, and business analytics. That framing matters because it mirrors a wider market push to connect medical records, revenue capture, and operational reporting in a single workflow for general practice teams. (todaysveterinarybusiness.com)
The roundup also shows how clinical focus areas like dermatology and nutrition continue to attract investment. Nestlé Purina said it donated to five veterinary schools, with support aimed at nutrition, dermatology, cognition, and canine performance research. Purina’s own announcement said the recipients were the University of Pennsylvania, Auburn, the University of Florida, Colorado State, and Cornell. At Florida, the company’s support helped establish an endowed professorship in veterinary dermatology for Domenico Santoro, whose research includes atopic dermatitis, skin barrier function, and host-microbe interactions. That gives the donation story more practical context: these aren’t just brand-building gestures, but targeted bets on disciplines that can shape both referral medicine and everyday primary care conversations with pet parents. (todaysveterinarybusiness.com)
Specialty expansion is another throughline. Thrive Pet Healthcare opened Dermatology for Animals Knoxville, its first Dermatology for Animals site in Tennessee and the 23rd location nationwide, according to Today’s Veterinary Business. That expansion fits a broader industry pattern in which multi-site groups are building regional specialty footprints in disciplines with persistent referral demand and long wait times. Dermatology remains especially important because chronic allergic and pruritic disease often requires ongoing case management, repeat visits, diet discussions, diagnostics, and long-term pet parent communication. (todaysveterinarybusiness.com)
Other items in the roundup reinforce the same picture of a market balancing innovation with practical clinical needs. Dechra’s Emeprev Injectable Solution won FDA approval for acute vomiting in dogs and vomiting in cats, while Elanco said its canine parvovirus monoclonal antibody received full USDA approval and will now be branded as Trutect. Patterson Veterinary also signed on to distribute LifePulse’s VetPulse 2000, an electroporation device positioned as a minimally invasive option for animal tumors. Taken together, those updates show that even in a software-heavy news cycle, therapeutics, diagnostics-adjacent tools, and oncology-related technologies are still moving forward through traditional regulatory and distribution channels. (todaysveterinarybusiness.com)
Expert commentary tied directly to these specific announcements was limited in public search results, but the strategic direction is consistent with broader industry analysis. Instinct Science’s recent market messaging emphasizes helping practices “capture every charge” while supporting safer care, and its 2026 general-practice report points to ongoing pressure on clinics to improve efficiency and financial performance without compromising medicine. That makes the company’s EMR launch more than a product update; it’s part of a larger argument that software purchasing is now a clinical and business decision at the same time. Inference: health systems and consolidators are likely to evaluate these tools not only on usability, but on whether they reduce documentation burden, tighten invoicing, and support staff retention. (instinct.vet)
Why it matters: For veterinary professionals, this roundup is less about any single headline and more about the direction of travel. AI scribes are moving from startup novelty toward institutional adoption, provided privacy review and consent guardrails are in place. Practice software vendors are competing on workflow integration and analytics, not just recordkeeping. Corporate funders are putting money into academic programs tied to high-impact clinical fields like dermatology and nutrition. And specialty networks continue to expand in areas where demand is durable and often under-served. For clinicians and practice leaders, that means decisions about technology, referrals, staffing, and client communication are becoming more interconnected. (todaysveterinarybusiness.com)
What to watch: The next phase will be whether these announcements produce evidence of real-world impact, including AI documentation adoption beyond pilot settings, stronger EMR conversion in general practice, additional academic-industry collaborations, and continued specialty buildout in secondary markets. If those trends hold through 2026, they’ll say a lot about where veterinary capital and clinical attention are concentrating next. (todaysveterinarybusiness.com)